Skip to Main Content

Paper Details

Functional proteomics of patient derived head and neck squamous cell carcinoma cells reveal novel applications of trametinib.
Cancer Biol Ther
4
2022
AXL, GDC-0032, GSK-690693, HNSCC, HNSCC cancer, MAPK, MEK, MET, SGX-523, VEGFR, axtinib, glesatinib, head and neck squamous, head and neck squamous cell carcinoma, head and neck squamous cell carcinoma cells, mitogen-activated protein kinase-kinase, patient, patients, resistant cell lines, trametinib, tumor, tumor-derived cell cultures
Head and Neck Neoplasms, Humans, Proteomics, Pyridones, Pyrimidinones, Squamous Cell Carcinoma of Head and Neck
Author NameAffiliation
Myles VigodaOregon Health & Science University
Myles VigodaMichigan State University College of Osteopathic Medicine
Chase MathiesonOregon Health & Science University
Nathaniel EvansDepartment of Medical Informatics and Clinical Epidemiolog, Oregon Health & Science University
Carolyn HaleOregon Health & Science University
Jennifer JenningsOregon Health & Science University
Olivia M LuceroOregon Health & Science University
Olivia M LuceroKnight Cancer Institute, Oregon Health & Science University
Sophia JengKnight Cancer Institute, Oregon Health & Science University
Sophia JengOregon Clinical and Translational Research Institute, Oregon Health & Science University
Daniel BottomlyKnight Cancer Institute, Oregon Health & Science University
Daniel R ClayburghOregon Health & Science University
Peter E AndersenOregon Health & Science University
Ryan LiOregon Health & Science University
Daniel PetrisorOregon Health & Science University
Jeffrey W TynerOregon Health & Science University
Shannon K McWeeneyDepartment of Medical Informatics and Clinical Epidemiolog, Oregon Health & Science University
Molly Kulesz-MartinOregon Health & Science University
Molly Kulesz-MartinOregon Health & Science University
  • 1 - 19

Datasets

Release 1.2